Q BioMed Inc.
Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
New York, New York--(Newsfile Corp. - February 26, 2019) - Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, today announced that in the February issue of DDNews, journalists conducted an interview with Q BioMed CEO Dennis Corin, focused on the mechanism of action, development path, and market opportunities ...2019-02-26 9:00 AM ET
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
New York, New York--(Newsfile Corp. - February 22, 2019) - Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announces multiple interviews with the company's CEO, Denis Corin, and the Q BioMed team are now available.An exclusive video interview with Chairman and CEO Denis Corin from the NASDAQ MarketSite. Mr. ...2019-02-22 9:00 AM ET